Steffen Breitfelder

This inventor holds 24 USPTO granted patents, plus 4 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steffen Breitfelder. Retrieved from https://idiyas.com/inventor/steffen-breitfelder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 373(Granted Patents)

Location History:

Ingelheim, DE (2002 - 2003)
Danbury, CT (US) (2002 - 2003)
Ridgefield, CT (US) (2006)
Assmannshardt, DE (2004 - 2010)
Aβmannshardt, DE (2010)
Attenweiler, DE (2012 - 2014)

Company Filing History:

11 out of 1,561

Boehringer Ingelheim International Gmbh

patents

6 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

6 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

4. 1 out of 149

Boehringer Ingelheim Pharma Kg

patents

Years Active: 2002-2014

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

PI3-Kinase Inhibitors

Anti-Inflammatory Agents

GPR119 Agonists

Dihydropteridinones

Thiazolyl Compounds

Carbamic Acid Esters

Bronchodilators

Intermediate Arylamine Compounds

Nitrogen Heterocycles

Indazoles

Quinazolines

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8822471 - Compounds, pharmaceutical compositions and uses thereof (2014-09-02),

2. 8772323 - Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists (2014-07-08),

3. 8410100 - Pteridinone derivatives as PI3-kinases inhibitors (2013-04-02),

4. 8354418 - Thiazolyl-dihydro-quinazolines (2013-01-15),

5. 8334378 - Thiazolyl-dihydro-quinazoline compounds and processes for preparing same (2012-12-18),

6. 8232286 - Inhibitors of PI3-kinases (2012-07-31),

7. 8207349 - Thiazolyl-dihydro-indazoles (2012-06-26),

8. 7750152 - Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the same (2010-07-06),

9. 7745621 - Long acting bronchodilators for the treatment of respiratory diseases (2010-06-29),

10. 7691888 - Thiazolyl-dihydro-indazole (2010-04-06),

11. 7691868 - Thiazolyl-dihydro-quinazoline (2010-04-06),

12. 7517995 - Thiazolyl-dihydro-cyclopentapyrazole (2009-04-14),

13. 7429601 - Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions (2008-09-30),

14. 7094788 - Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions (2006-08-22),

15. 7041674 - Carbamic acid esters with anticholinergic activity (2006-05-09),

Title: Inventor Spotlight: Steffen Breitfelder

Introduction:

Steffen Breitfelder, a talented inventor hailing from Assmannshardt, DE, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 24 patents.

Latest Patents:

Breitfelder's recent patents highlight his expertise in developing compounds and pharmaceutical compositions with valuable pharmacological properties. One notable patent revolves around compounds that bind to the GPR119 receptor, modulating its activity. Another patent delves into benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists.

Career Highlights:

Throughout his career, Breitfelder has showcased his innovative prowess at renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. He has played a pivotal role in advancing pharmaceutical research and development within these esteemed organizations.

Collaborations:

Collaboration is key to innovation, and Breitfelder has had the privilege of working alongside notable individuals in the field. Among his coworkers are Matthias Grauert and Matthias Hoffmann, who have undoubtedly contributed to the success of their collaborative projects.

Conclusion:

In conclusion, Steffen Breitfelder stands as a trailblazing inventor whose inventive spirit has propelled advancements in pharmaceuticals. His dedication to developing novel compounds and pharmaceutical compositions underscores his commitment to improving global healthcare. Breitfelder's impressive patent portfolio speaks volumes about his ingenuity and invaluable contributions to the field of life sciences.

Profile summary based on public USPTO records.